Promise of Bispecific Antibodies in MM

Promise of Bispecific Antibodies in MM

User Photo
obr

1 year
84 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Robert Rifkin, MD, McKesson Biosimilars, Associate Chair, Rocky Mountain Cancer Centers explains the promise of bispecific antibodies in multiple myeloma (MM) treatment for patients.
Up Next Autoplay
>